Recombinomics | Elegant Evolution






Home Founder What's New In The News Consulting





























H1N1 Consulting

Paradigm Shift

Viral Evolution

Intervention Monitoring

Vaccine Screening

Vaccine Development

Expression Profiling

Drug Discovery

Custom Therapies

Patents



Audio:Jan21 Feb2 Feb13 Feb18 RSS Feed twitter News Now                         
Live feed of underlying pandemic map data here
Commentary

H1N1 H274Y Tamiflu Resistance in Italian Recombinant
Recombinomics Commentary 18:29
February 28, 2010

Azienda Ospedaliero Universitaria Pisana has release a partial NA sequences from a recently treated immune-suppressed patient.  The sequence, A/Italy/Pisa254/2010, has a mixed signal for H274Y.  The January 26, 2010 collection is the most recent H274Y positive sequence to date and there are five additional recent synonymous acquisitions. The first two are found in four isolates from Jiangyin (see list here) indicating they were acquired via recombination.  The mixed signal for H274Y also supports the presence of a mixture with H274Y selected by the treatment.  In immune-suppressed patients, monitoring is more active, and the likelihood of resistant strains producing clinical problems is increased because of a compromised immune system.

The release of this sequence follows the release of 13 recent sequences from Japan.  10 had H274Y, including a January, 2010 collection.  The increased detection of H274Y in the limited number of 2010 sequences raises concerns that Tamiflu resistance, like D225G/N, is on the rise.

These markers move around via recombination, which allows for jumping from one genetic background to another.  In the Italian NA sequence there fist polymorphism matched the two polymorphisms in China, which provide another example of recombination.  These examples are difficult to explain by the “random mutation” paradigm of WHO and collaborators.  The H274Y in the above isolate is on yet another genetic background, adding further support for recombination.  D225G/N has also been found on multiple genetic backgrounds, in addition to concentration in one sub-clade found largely, in Ukraine and Russia.

These increasing frequencies of H274Y and D225G/N raise concerns that as a new wave develops, new variants will arise with D225G/N and H274Y.

The increasing reports of H274Y in 2010 isolates add to those concerns.

Media Links

Recombinomics Presentations

Recombinomics Publications

Recombinomics Paper at Nature Precedings
















Home | Founder | What's New | In The News | Contact Us

Webmaster: webmaster@recombinomics.com
© 2010 Recombinomics.  All rights reserved.